Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Recombinant human insulin receptor monoclonal antibody-fused-α-L-iduronidase

EU orphan designation number: EU/3/14/1349   
Active ingredient: Recombinant human insulin receptor monoclonal antibody-fused-α-L-iduronidase
Indication: Treatment of mucopolysaccharidosis type I
Sponsor: Voisin Consulting S.A.R.L.
64 avenue Pierre Grenier, 92100 Boulogne Billancourt, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
17/10/2014 Orphan designation EMA/OD/138/14 (2014)7648 of 15/10/2014
22/05/2017 Change of name and/or address of sponsor